Research Project
Grant-in-Aid for Scientific Research (C)
(Background &Aim) CXCL16 is selectively expressed on only APC such as dendritic cells and macrophages. CXCL16 supports binding and phagocytosis of both gram-positive and negative bacteria through the chemokine-domain, suggesting that it may be involved in facilitating uptake of various pathogens and APC-T cell interactions in initiation of immune response. In this regard, it may be interesting to speculate that the interaction between APC and T cells through CXCL16 in response to various stimuli such as luminal bacteria components is involved in the pathophysiology of IBD. Therefore, the aim of the present study is to examine whether or not regulation of CXCL16 is effective for inflammatory bowel disease. (Methods) We generate CXCL16 knock out mice and anti-CXCL16mAbIgG1 and anti-human CXCL16mAbs. Induction of Colitis: To induce colitis, C57BL/6 mice are given 3%DSS (mol wt, 36-50 kilodaltons) in their drinking water for 5 days (from day 0 to 4). TNBS colitis is induced in SJL/J mice by using a modification of the method described by Neurath et. Al. Clinical evaluation after treatment by anti-CXCL16mAb: After induction of colitis, mice are injected with 500μg anti-CXCL16mAb or control rat IgG. For 5 days. (Results) Administration of anti-CXCL16 antibody dramatically decreased the severity of colonic inflammation in both DSS and TNBS colitis models. Production of both TNF-α and IFN-γ from mesenteric lymph node cells will be significantly lower in the group treated with anti-CXCL16 antibody than in non-treated group. The number of lymphocytes of CD4^+ CD69^+ T cells from the MLN in the mice treated with anti-CXCL16 was significantly lower than those in non-treated group. These finding suggested that CXCL16 is one of the most important chemokines, which is involved in the intestinal inflammation. (Conclusion) This data demonstrate the first evidence that dysregulation of CXCL16 activity is one of the important pathogenetic factor for human IBD.
All 2008 2007 2006 Other
All Journal Article (34 results) (of which Peer Reviewed: 4 results) Presentation (13 results)
J Gastroenterol Hepatol. (in press)
J Gastroenterol Hepatol. 22
Pages: 984-988
Inflamm Bowel Dis. 13
Pages: 1516-1521
Gastrointest Endosc 65
Pages: 156-157
Inflamm Bowel Dis 13
Pages: 802-803
Intern Med 46
Pages: 141-142
130000078579
J Gastroenterol Hepatol 22
Pages: 446-446
Pages: 760-760
Pages: 717-720
130000076720
Pages: 545-547
Pages: 1346-1346
Gastroenterology 133
Clin Gastroenterol Hepatol 5
Case Reports in Gastroenterology 1
Pages: 157-161
Pages: 364-364
Gastrointest Endosc 66(3 Suppl)
Helicobacter 12
Pages: 486-97
Lancet 368(9549)
Pages: 1842-1842
Dig Dis Sci 51
Pages: 1052-1055
Gastroenterology 131
Pages: 1110-1121
Lancet 368
Inflamm Bowel Dis (in press)
J Gastroenterol Hepatol (in press)
Intern Med (in press)